+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-12-06Number of Pages: 172

Drugs of Abuse Testing Market (Products - Analyzers (Immunoassays Analyzers, Chromatographic Devices, and Breath Analyzers), Rapid Testing Devices (Urine Testing Devices and Oral Fluid Testing Devices), and Consumables (Fluid Collection Devices); Sample - Saliva, Breath, Urine, Blood, Hair, and Sweat; Testing - Pain Management Testing, Criminal Justice Testing, and Work Place Screening; End User - Forensic Laboratories, Diagnostic Labs, On-the-spot Testing, Hospitals, and Forensic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Drugs – of – Abuse Testing Market  

4. Market Overview
     4.1. Introduction
             4.1.1. Product Definition
             4.1.2. Industry Evolution / Developments
     4.2. Market Overview
     4.3. Regulatory Scenario
     4.4. Market Dynamics
             4.4.1. Drivers
             4.4.2. Restraints
             4.4.3. Opportunities
             4.4.4. Trends
     4.5. Market Revenue Projections (US$ Mn)
     4.6. Market Outlook
     4.7. Porter’s Five Forces Analysis 
     4.8. Value Chain Analysis
     4.9. Technology Assessment 
     4.10. Global Demand and Supply Scenario 

5. Global Drugs – of – Abuse Testing  Market Analysis and Forecast, By Product Type
     5.1. Introduction 
     5.2. Product Comparison Matrix 
     5.3. Market Revenue Share (US$) and Attractiveness Analysis, By Product Type
     5.4. Market Size (US$ Mn) Forecast, By  Product Type  
             5.4.1. Analyzers 
                       5.4.1.1. Immunoassay Analyzers
                       5.4.1.2. Chromatographic Devices
                       5.4.1.3. Breath Analyzers
             5.4.2. Rapid Testing Devices
                       5.4.2.1. Urine Testing Devices 
                       5.4.2.2. Oral Fluid Testing Devices
             5.4.3. Consumables
                       5.4.3.1. Fluid Collection Devices
                       5.4.3.2. Others

6. Global Drugs – of – Abuse Testing  Market Analysis and Forecast, By Sample Type
     6.1. Introduction 
     6.2. Market Revenue Share (US$) and Attractiveness Analysis, By Sample Type 
     6.3. Market Size (US$ Mn) Forecast, By Sample Type  
             6.3.1. Saliva
             6.3.2. Breath
             6.3.3. Urine
             6.3.4. Blood
             6.3.5. Hair & Sweat

7. Global   Drugs – of – Abuse Testing  Market Analysis and Forecast, By Testing Type
     7.1. Introduction 
     7.2. Market Revenue Share (US$) and Attractiveness Analysis, By Testing Type 
     7.3. Market Size (US$ Mn) Forecast, By Testing Type  
             7.3.1. Pain Management Testing
             7.3.2. Criminal Justice Testing
             7.3.3. Work Place Screening

8. Global   Drugs – of – Abuse Testing  Market Analysis and Forecast, By End User 
     8.1. Introduction 
     8.2. Market Revenue Share (US$) and Attractiveness Analysis, By End User 
     8.3. Market Size (US$ Mn) Forecast, By End User  
             8.3.1. Hospitals
             8.3.2. Diagnostics Laboratories
             8.3.3. On-the-spot Testing
             8.3.4. Forensic Laboratories

9. Global   Drugs – of – Abuse Testing  Market Analysis and Forecast, By Region 
     9.1. Market Revenue Share (US$) and Attractiveness Analysis, By Region 
     9.2. Market Size (US$ Mn) Forecast, By Region  
             9.2.1. North America
             9.2.2. Europe
             9.2.3. Asia Pacific
             9.2.4. Latin America
             9.2.5. Middle East and Africa

10. North  Drugs – of – Abuse Testing Market Analysis and Forecast
     10.1. Market Overview
             10.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
             10.1.2. Testing Market Attractiveness Analysis, by Country
     10.2. Market Value Share Analysis by Product Type  
             10.2.1. Analyzers 
                       10.2.1.1. Immunoassay Analyzers
                       10.2.1.2. Chromatographic Devices
                       10.2.1.3. Breath Analyzers
             10.2.2. Rapid Testing Devices
                       10.2.2.1. Urine Testing Devices 
                       10.2.2.2. Oral Fluid Testing Devices
             10.2.3. Consumables
                       10.2.3.1. Fluid Collection Devices
                       10.2.3.2. Others Sub-mucosal Fibroids
     10.3. Market Value Share Analysis by Sample Type  
             10.3.1. Saliva
             10.3.2. Breath
             10.3.3. Urine
             10.3.4. Blood
             10.3.5. Hair & Sweat
     10.4. Market Value Share Analysis by Testing Type  
             10.4.1. Pain Management 
             10.4.2. Criminal Justice Testing 
             10.4.3. Work Place Screening
     10.5. Market Value Share Analysis by End User  
             10.5.1. Hospitals 
             10.5.2. Diagnostics Laboratories
             10.5.3. On – the – Spot Testing
             10.5.4. Forensic Laboratories
     10.6. Market Value Share Analysis by Country  
             10.6.1. U.S.
             10.6.2. Canada
     10.7. Market Size (US$ Mn) Forecast
             10.7.1. By Product Type
             10.7.2. By Sample Type
             10.7.3. By Testing Type
             10.7.4. By End User
             10.7.5. By Country
     10.8. Market Attractiveness Analysis 
             10.8.1. By Product Type
             10.8.2. By Sample Type
             10.8.3. By Testing Type
             10.8.4. By End User

11. Latin America  Drugs – of – Abuse Testing Market Analysis and Forecast
     11.1. Market Overview
             11.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
             11.1.2. Testing Market Attractiveness Analysis, by Country
     11.2. Market Value Share Analysis by Product Type  
             11.2.1. Analyzers 
                       11.2.1.1. Immunoassay Analyzers
                       11.2.1.2. Chromatographic Devices
                       11.2.1.3. Breath Analyzers
             11.2.2. Rapid Testing Devices
                       11.2.2.1. Urine Testing Devices 
                       11.2.2.2. Oral Fluid Testing Devices
             11.2.3. Consumables
                       11.2.3.1. Fluid Collection Devices
                       11.2.3.2. Others Sub-mucosal Fibroids
     11.3. Market Value Share Analysis by Sample Type  
             11.3.1. Saliva
             11.3.2. Breath
             11.3.3. Urine
             11.3.4. Blood
             11.3.5. Hair & Sweat
     11.4. Market Value Share Analysis by Testing Type  
             11.4.1. Pain Management 
             11.4.2. Criminal Justice Testing 
             11.4.3. Work Place Screening     
     11.5. Market Value Share Analysis by End User  
             11.5.1. Hospitals 
             11.5.2. Diagnostics Laboratories
             11.5.3. On – the – Spot Testing
             11.5.4. Forensic Laboratories
     11.6. Market Value Share Analysis by Country  
             11.6.1. Mexico
             11.6.2. Brazil
             11.6.3. Rest of Latin America
     11.7. Market Size (US$ Mn) Forecast
             11.7.1. By Product Type
             11.7.2. By Sample Type
             11.7.3. By Testing Type
             11.7.4. By End User
             11.7.5. By Country
     11.8. Market Attractiveness Analysis 
             11.8.1. By Product Type
             11.8.2. By Sample Type
             11.8.3. By Testing Type
             11.8.4. By End User

12. Europe Drugs – of – Abuse Testing Market Analysis and Forecast
     12.1. Market Overview
             12.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
             12.1.2. Testing Market Attractiveness Analysis, by Country
     12.2. Market Value Share Analysis by Product Type  
             12.2.1. Analyzers 
                       12.2.1.1. Immunoassay Analyzers
                       12.2.1.2. Chromatographic Devices
                       12.2.1.3. Breath Analyzers
             12.2.2. Rapid Testing Devices
                       12.2.2.1. Urine Testing Devices 
                       12.2.2.2. Oral Fluid Testing Devices
             12.2.3. Consumables
                       12.2.3.1. Fluid Collection Devices
                       12.2.3.2. Others Sub-mucosal Fibroids
     12.3. Market Value Share Analysis by Sample Type  
             12.3.1. Saliva
             12.3.2. Breath
             12.3.3. Urine
             12.3.4. Blood
             12.3.5. Hair & Sweat
     12.4. Market Value Share Analysis by Testing Type  
             12.4.1. Pain Management 
             12.4.2. Criminal Justice Testing 
             12.4.3. Work Place Screening
     12.5. Market Value Share Analysis by End User  
             12.5.1. Hospitals 
             12.5.2. Diagnostics Laboratories
             12.5.3. On – the – Spot Testing
             12.5.4. Forensic Laboratories
     12.6. Market Value Share Analysis by Country  
             12.6.1. U.K.
             12.6.2. France
             12.6.3. Germany
             12.6.4. Italy
             12.6.5. Spain
             12.6.6. Russia
             12.6.7. Rest of Europe
     12.7. Market Size (US$ Mn) Forecast
             12.7.1. By Product Type
             12.7.2. By Sample Type
             12.7.3. By Testing Type
             12.7.4. By End User
             12.7.5. By Country
     12.8. Market Attractiveness Analysis 
             12.8.1. By Product Type
             12.8.2. By Sample Type
             12.8.3. By Testing Type
             12.8.4. By End User

13. APAC Drugs – of – Abuse Testing Market Analysis and Forecast
     13.1. Market Overview
             13.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
             13.1.2. Testing Market Attractiveness Analysis, by Country
     13.2. Market Value Share Analysis by Product Type  
             13.2.1. Analyzers 
                       13.2.1.1. Immunoassay Analyzers
                       13.2.1.2. Chromatographic Devices
                       13.2.1.3. Breath Analyzers
             13.2.2. Rapid Testing Devices
                       13.2.2.1. Urine Testing Devices 
                       13.2.2.2. Oral Fluid Testing Devices
             13.2.3. Consumables
                       13.2.3.1. Fluid Collection Devices
                       13.2.3.2. Others Sub-mucosal Fibroids
     13.3. Market Value Share Analysis by Sample Type  
             13.3.1. Saliva
             13.3.2. Breath
             13.3.3. Urine
             13.3.4. Blood
             13.3.5. Hair & Sweat
     13.4. Market Value Share Analysis by Testing Type  
             13.4.1. Pain Management 
             13.4.2. Criminal Justice Testing 
             13.4.3. Work Place Screening
     13.5. Market Value Share Analysis by End User  
             13.5.1. Hospitals 
             13.5.2. Diagnostics Laboratories
             13.5.3. On – the – Spot Testing
             13.5.4. Forensic Laboratories
     13.6. Market Value Share Analysis by Country  
             13.6.1. Japan
             13.6.2. China
             13.6.3. India
             13.6.4. Australia & New Zealand
             13.6.5. Rest of APAC
     13.7. Market Size (US$ Mn) Forecast
             13.7.1. By Product Type
             13.7.2. By Sample Type
             13.7.3. By Testing Type
             13.7.4. By End User
             13.7.5. By Country
     13.8. Market Attractiveness Analysis 
             13.8.1. By Product Type
             13.8.2. By Sample Type
             13.8.3. By Testing Type
             13.8.4. By End User

14. MEA Drugs – of – Abuse Testing Market Analysis and Forecast
     14.1. Market Overview
             14.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
             14.1.2. Testing Market Attractiveness Analysis, by Country
     14.2. Market Value Share Analysis by Product Type  
             14.2.1. Analyzers 
                       14.2.1.1. Immunoassay Analyzers
                       14.2.1.2. Chromatographic Devices
                       14.2.1.3. Breath Analyzers
             14.2.2. Rapid Testing Devices
                       14.2.2.1. Urine Testing Devices 
                       14.2.2.2. Oral Fluid Testing Devices
             14.2.3. Consumables
                       14.2.3.1. Fluid Collection Devices
                       14.2.3.2. Others Sub-mucosal Fibroids
     14.3. Market Value Share Analysis by Sample Type  
             14.3.1. Saliva
             14.3.2. Breath
             14.3.3. Urine
             14.3.4. Blood
             14.3.5. Hair & Sweat
     14.4. Market Value Share Analysis by Testing Type  
             14.4.1. Pain Management 
             14.4.2. Criminal Justice Testing 
             14.4.3. Work Place Screening
     14.5. Market Value Share Analysis by End User  
             14.5.1. Hospitals 
             14.5.2. Diagnostics Laboratories
             14.5.3. On – the – Spot Testing
             14.5.4. Forensic Laboratories
     14.6. Market Value Share Analysis by Country  
             14.6.1. GCC Countries 
             14.6.2. South Africa
             14.6.3. Rest of MEA
     14.7. Market Size (US$ Mn) Forecast
             14.7.1. By Product Type
             14.7.2. By Sample Type
             14.7.3. By Testing Type
             14.7.4. By End User
             14.7.5. By Country
     14.8. Market Attractiveness Analysis 
             14.8.1. By Product Type
             14.8.2. By Sample Type
             14.8.3. By Testing Type
             14.8.4. By End User

15. Competition Landscape
     15.1. Market Player – Competition Matrix 
     15.2. Market Share Analysis By Company (2015)
     15.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
             15.3.1. F. Hoffmann La-Roche Ltd
                       15.3.1.1. Company Details
                       15.3.1.2. Company Description
                       15.3.1.3. Business Overview
                       15.3.1.4. SWOT Analysis
                       15.3.1.5. Strategic Overview
             15.3.2. Siemens Healthineers (Siemens AG)
                       15.3.2.1. Company Details
                       15.3.2.2. Company Description
                       15.3.2.3. Business Overview
                       15.3.2.4. SWOT Analysis
                       15.3.2.5. Strategic Overview
             15.3.3. Thermo Fisher Scientific, Inc.
                       15.3.3.1. Company Details
                       15.3.3.2. Company Description
                       15.3.3.3. Business Overview
                       15.3.3.4. SWOT Analysis
                       15.3.3.5. Strategic Overview
             15.3.4. Alere, Inc.
                       15.3.4.1. Company Details
                       15.3.4.2. Company Description
                       15.3.4.3. Business Overview
                       15.3.4.4. SWOT Analysis
                       15.3.4.5. Strategic Overview
             15.3.5. Shimadzu Corporation
                       15.3.5.1. Company Details
                       15.3.5.2. Company Description
                       15.3.5.3. Business Overview
                       15.3.5.4. SWOT Analysis
                       15.3.5.5. Strategic Overview
             15.3.6. Laboratory Corporation of America Holdings
                       15.3.6.1. Company Details
                       15.3.6.2. Company Description
                       15.3.6.3. Business Overview
                       15.3.6.4. SWOT Analysis
                       15.3.6.5. Strategic Overview
             15.3.7. Drägerwerk AG & Co. KGaA
                       15.3.7.1. Company Details
                       15.3.7.2. Company Description
                       15.3.7.3. Business Overview
                       15.3.7.4. SWOT Analysis
                       15.3.7.5. Strategic Overview
             15.3.8. Express Diagnostics International Inc.
                       15.3.8.1. Company Details
                       15.3.8.2. Company Description
                       15.3.8.3. Business Overview
                       15.3.8.4. SWOT Analysis
                       15.3.8.5. Strategic Overview

List of Figures

Figure 1: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, 2016–2024
Figure 2: Global Drug of Abuse Testing Market Value Share By Product Type (2016)
Figure 3: Global Drug of Abuse Testing Market Value Share By Sample Type (2016)
Figure 4: Global Drug of Abuse Testing Market Value Share By Testing Type (2016)
Figure 5: Global Drug of Abuse Testing Market Value Share By End User (2016)
Figure 6: Global Drug of Abuse Testing Market Value Share By Region (2016)
Figure 7: Global Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 8: Global Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2015
Figure 9: Global Analyzers Market Revenue (US$ Mn) 2016–2024
Figure 10: Global Rapid Testing Devices Market Revenue (US$ Mn), 2016–2024
Figure 11: Global Consumables Market Revenue (US$ Mn) 2016–2024
Figure 12: Global Drug of Abuse Testing Market Value Share Analysis By Sample Type, 2016 and 2024
Figure 13: Global Drug of Abuse Testing Market Attractiveness Analysis By Sample Type, 2015
Figure 14: Global Saliva Market Revenue (US$ Mn) 2016–2024
Figure 15: Global Breath Market Revenue (US$ Mn), 2016–2024
Figure 16: Global Urine Market Revenue (US$ Mn), 2016–2024
Figure 17: Global Blood Market Revenue (US$ Mn), 2016–2024
Figure 18: Global Hair and Sweat Market Revenue (US$ Mn), 2016–2024
Figure 19: Global Drug of Abuse Testing Market Value Share Analysis, by Testing Type, 2016 and 2024
Figure 20: Global Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2015
Figure 21: Global Pain Management Testing Market Revenue (US$ Mn) 2016–2024
Figure 22: Global Criminal Justice Testing Market Revenue (US$ Mn), 2016–2024
Figure 23: Global Work Place Screening Market Revenue (US$ Mn) 2016–2024
Figure 24: Global Drug of Abuse Testing Market Value Share Analysis, by End User, 2016 and 2024
Figure 25: Global Drug of Abuse Testing Market Attractiveness Analysis, by End User, 2015
Figure 26: Global Hospital Market Revenue (US$ Mn) 2016–2024
Figure 27: Global Diagnostic Laboratories Market Revenue (US$ Mn), 2016–2024
Figure 28: Global On-the-spot Testing Market Revenue (US$ Mn) 2016–2024
Figure 29: Global Forensic Laboratories Market Revenue (US$ Mn), 2016–2024
Figure 30: Global Drug of Abuse Testing Market Value Share Analysis By Region, 2016 and 2024
Figure 31: Global Drug of Abuse Testing Market Attractiveness Analysis, By Region, 2015
Figure 32: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 33: North America Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2015
Figure 34: North America Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 35: North America Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2016 and 2024
Figure 36: North America Drug of abuse testing Market Value Share Analysis, by Testing Type, 2016 and 2024
Figure 37: North America Drug of abuse testing Market Value Share Analysis, by End-user, 2016 and 2024
Figure 38: North America Drug of Abuse Testing Market Value Share Analysis, by Country, 2016 and 2024
Figure 39: North America Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2015
Figure 40: North America Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2015
Figure 41: North America Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2015
Figure 42: North America Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2015
Figure 43: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 44: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2015
Figure 45: Latin America Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 46: Latin America Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2016 and 2024
Figure 47: Latin America Drug of abuse testing Market Value Share Analysis, by Testing Type, 2016 and 2024
Figure 48: Latin America Drug of abuse testing Market Value Share Analysis, by End-user, 2016 and 2024
Figure 49: Latin America Drug of Abuse Testing Market Value Share Analysis, by Country, 2016 and 2024
Figure 50: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2015
Figure 51: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2015
Figure 52: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2015
Figure 53: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2015
Figure 54: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 55: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2015
Figure 56: Europe Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 57: Europe Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2016 and 2024
Figure 58: Europe Drug of abuse testing Market Value Share Analysis, by Testing Type, 2016 and 2024
Figure 59: Europe Drug of abuse testing Market Value Share Analysis, by End-user, 2016 and 2024
Figure 60: Europe Drug of Abuse Testing Market Value Share Analysis, by Country, 2016 and 2024
Figure 61: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2015
Figure 62: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2015
Figure 63: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2015
Figure 64: Europe Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2015
Figure 65: APAC Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 66: APAC Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2015
Figure 67: APAC Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 68: APAC Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2016 and 2024
Figure 69: APAC Drug of abuse testing Market Value Share Analysis, by Testing Type, 2016 and 2024
Figure 70: APAC Drug of abuse testing Market Value Share Analysis, by End-user, 2016 and 2024
Figure 71: APAC Drug of Abuse Testing Market Value Share Analysis, by Country, 2016 and 2024
Figure 72: APAC Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2015
Figure 73: APAC Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2015
Figure 74: APAC Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2015
Figure 75: APAC Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2015
Figure 76: MEA Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 77: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2015
Figure 78: MEA Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 79: MEA Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2016 and 2024
Figure 80: MEA Drug of abuse testing Market Value Share Analysis, by Testing Type, 2016 and 2024
Figure 81: MEA Drug of abuse testing Market Value Share Analysis, by End-user, 2016 and 2024
Figure 82: MEA Drug of Abuse Testing Market Value Share Analysis, by Country, 2016 and 2024
Figure 83: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2015
Figure 84: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2015
Figure 85: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2015
Figure 86: MEA Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2015
Figure 87: Global Drugs – of – Abuse Testing Market, Company Share Analysis, 2015
Figure 81: MEA Drug of abuse testing Market Value Share Analysis, by End-user, 2016 and 2024
Figure 82: MEA Drug of Abuse Testing Market Value Share Analysis, by Country, 2016 and 2024
Figure 83: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2015

List of Tables

Table 1: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, By Product Type, 2016–2024 (1/2)
Table 2: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, By Sample Type, 2016–2024
Table 3: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, By Testing Type, 2016–2024
Table 4: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 5: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, By Region, 2016–2024
Table 6: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016–2024 
Table 7: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016–2024
Table 8: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016–2024
Table 9: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 10: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 11: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016–2024 
Table 12: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016–2024
Table 13: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016–2024
Table 14: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 15: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 16: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016–2024 (1/2)
Table 17: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016–2024
Table 18: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016–2024
Table 19: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 20: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 21: APAC Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016–2024 
Table 22: APAC Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016–2024
Table 23: APAC Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016–2024
Table 24: APAC Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 25: APAC Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 26: MEA Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016–2024 
Table 27: MEA Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016–2024
Table 28: MEA Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016–2024
Table 29: MEA Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 30: MEA Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2016–2024


 
 
Back To Top